Foley & Lardner LLP Partner Dan Kaplan was quoted in a Bloomberg Law article, “Shot-or-Test Time Arrives with OSHA Resolute, Employers in Limbo,” that discusses the first day that OSHA could begin citing employers for violating the agency’s COVID-19 shot-or-test emergency temporary standard.
“OSHA has stated that it will exercise its executive prosecutorial discretion to refrain from citing an employer for a violation of the ETS if the employer can show that it is working in good faith for the implementation of compliance with those requirements,” Kaplan shared with Bloomberg Law.
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."